Analysis of the Impact of Tofacitinib Treatment on Weight in Patients with Rheumatoid Arthritis

被引：0
|
作者：
Wollenhaupt, Juergen [1 ]
Morel, Jacques [2 ,3 ]
Daien, Claire [3 ,4 ]
Ruyssen-Witrand, Adeline [5 ]
Lukas, Cedric [3 ,4 ]
Richez, Christophe [6 ]
Shapiro, Andrea [7 ]
Chapman, Douglass S. [8 ]
Cros, Magali [9 ]
Rivas, Jose L. [10 ]
Citera, Gustavo [11 ]
机构：
[1] Struenseehaus Ctr Rheumatol & Clin Immunol, Hamburg, Germany
[2] CHU Montpellier, Dept Rheumatol, Montpellier, France
[3] Univ Montpellier, Montpellier, France
[4] CHU Montpellier, Montpellier, France
[5] CHU Toulouse, Hop Purpan, Toulouse, France
[6] CHU Bordeaux, Grp Hosp Pellegrin, Bordeaux, France
[7] Pfizer Inc, Peapack, NJ USA
[8] Pfizer Inc, New York, NY USA
[9] Pfizer Inc, Paris, France
[10] Pfizer SLU, Madrid, Spain
[11] Inst Rehabil Psicofis, Buenos Aires, DF, Argentina
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1203
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Clinical Management of Herpes Zoster in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Receiving Tofacitinib Treatment
    Kevin L. Winthrop
    Jeffrey R. Curtis
    Kunihiro Yamaoka
    Eun Bong Lee
    Tomohiro Hirose
    Jose L. Rivas
    Kenneth Kwok
    Gerd R. Burmester
    Rheumatology and Therapy, 2022, 9 : 243 - 263
  • [32] Clinical Management of Herpes Zoster in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Receiving Tofacitinib Treatment
    Winthrop, Kevin L.
    Curtis, Jeffrey R.
    Yamaoka, Kunihiro
    Lee, Eun Bong
    Hirose, Tomohiro
    Rivas, Jose L.
    Kwok, Kenneth
    Burmester, Gerd R.
    RHEUMATOLOGY AND THERAPY, 2022, 9 (01) : 243 - 263
  • [33] Treatment of Refractory Chronic Pruritus of Unknown Origin With Tofacitinib in Patients With Rheumatoid Arthritis
    Wang, Fang
    Morris, Caroline
    Bodet, Nancy D.
    Kim, Brian S.
    JAMA DERMATOLOGY, 2019, 155 (12) : 1426 - 1428
  • [34] Impact of the HLA-DRB1 shared epitope on responses to treatment with tofacitinib or abatacept in patients with rheumatoid arthritis
    Wataru Hirose
    Masayoshi Harigai
    Koichi Amano
    Toshihiko Hidaka
    Kenji Itoh
    Kazutoshi Aoki
    Masahiro Nakashima
    Hayato Nagasawa
    Yukiko Komano
    Toshihiro Nanki
    Arthritis Research & Therapy, 23
  • [35] Impact of the HLA-DRB1 shared epitope on responses to treatment with tofacitinib or abatacept in patients with rheumatoid arthritis
    Hirose, Wataru
    Harigai, Masayoshi
    Amano, Koichi
    Hidaka, Toshihiko
    Itoh, Kenji
    Aoki, Kazutoshi
    Nakashima, Masahiro
    Nagasawa, Hayato
    Komano, Yukiko
    Nanki, Toshihiro
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [36] Safety of Tofacitinib in the Treatment of Rheumatoid Arthritis: a Systematic Review and Meta-Analysis
    He, Y.
    Wong, A.
    Chan, E.
    Lau, W.
    Man, K.
    Chui, C.
    Worsley, A.
    Wong, I.
    DRUG SAFETY, 2013, 36 (09) : 852 - 853
  • [37] A pharmacokinetic and clinical assessment of tofacitinib for the treatment of rheumatoid arthritis
    Bannwarth, Bernard
    Kostine, Marie
    Poursac, Nicolas
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (06) : 753 - 761
  • [38] BUDGET IMPACT ANALYSIS OF THE INCLUSION OF TOFACITINIB AS AN ALTERNATIVE FOR RHEUMATOID ARTHRITIS TREATMENT AFTER CONVENTIONAL DMARDS FAILURE IN CHILE
    Gutierrez-Ardila, M., V
    VALUE IN HEALTH, 2016, 19 (03) : A228 - A229
  • [39] Treatment Patterns and Effectiveness of Tofacitinib in Patients Initiating Therapy for Rheumatoid Arthritis: Results From the CorEvitas Rheumatoid Arthritis Registry
    Pappas, Dimitrios A.
    O'Brien, Jacqueline
    Moore, Page C.
    Dodge, Rhiannon
    Germino, Rebecca
    Masri, Karim R.
    Bingham III, Clifton O.
    Cappelli, Laura C.
    JOURNAL OF RHEUMATOLOGY, 2024, 51 (05) : 452 - 461
  • [40] The impact of rheumatoid arthritis and treatment on patients' lives
    Strand, V.
    Khanna, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (03) : S32 - S40
12345